The benefit of allogeneic stem cell transplantation for treating blood cancers partly depends on the intensive chemoradiotherapy that is given before stem cell infusion.

• 异基因造血干细胞移植治疗恶性血液疾病的好处，部分依赖于干细胞输注前的高强度化疗。